Search Results - "Dunnwald, Lisa K"

Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients by Dunnwald, Lisa K, Rossing, Mary Anne, Li, Christopher I

“…Breast cancer patients with tumors that are estrogen receptor (ER)-positive and/or progesterone receptor (PR)-positive have lower risks of mortality after…”
Get full text

Quantitative Fluoroestradiol Positron Emission Tomography Imaging Predicts Response to Endocrine Treatment in Breast Cancer by LINDEN, Hannah M, STEKHOVA, Svetlana A, KROHN, Kenneth A, MANKOFF, David A, LINK, Jeanne M, GRALOW, Julie R, LIVINGSTON, Robert B, ELLIS, Georgiana K, PETRA, Philip H, PETERSON, Lanell M, SCHUBERT, Erin K, DUNNWALD, Lisa K

“…In breast cancer, [(18)F]fluoroestradiol (FES) positron emission tomography (PET) correlates with estrogen receptors (ER) expression and predicts response to…”
Get full text

PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake by DUNNWALD, Lisa K, DOOT, Robert K, MUZI, Mark, MANKOFF, David A, SPECHT, Jennifer M, GRALOW, Julie R, ELLIS, Georgiana K, LIVINGSTON, Robert B, LINDEN, Hannah M, GADI, Vijayakrishna K, KURLAND, Brenda F, SCHUBERT, Erin K

“…Changes in tumor metabolism from positron emission tomography (PET) in locally advanced breast cancer (LABC) patients treated with neoadjuvant chemotherapy…”
Get full text

Tumor Metabolism and Blood Flow Changes by Positron Emission Tomography: Relation to Survival in Patients Treated With Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer by DUNNWALD, Lisa K, GRALOW, Julie R, SCHUBERT, Erin K, MANKOFF, David A, ELLIS, Georgiana K, LIVINGSTON, Robert B, LINDEN, Hannah M, SPECHT, Jennifer M, DOOT, Robert K, LAWTON, Thomas J, BARLOW, William E, KURLAND, Brenda F

“…Patients with locally advanced breast carcinoma (LABC) receive preoperative chemotherapy to provide early systemic treatment and assess in vivo tumor response…”
Get full text

Tumor Metabolism and Blood Flow as Assessed by Positron Emission Tomography Varies by Tumor Subtype in Locally Advanced Breast Cancer by SPECHT, Jennifer M, KURLAND, Brenda F, SCHUBERT, Erin K, MANKOFF, David A, MONTGOMERY, Susan K, DUNNWALD, Lisa K, DOOT, Robert K, GRALOW, Julie R, ELLIS, Georgina K, LINDEN, Hannah M, LIVINGSTON, Robert B, ALLISON, Kimberly H

“…Dynamic positron emission tomography (PET) imaging can identify patterns of breast cancer metabolism and perfusion in patients receiving neoadjuvant…”
Get full text

Blood Flow-Metabolism Mismatch: Good for the Tumor, Bad for the Patient by MANKOFF, David A, DUNNWALD, Lisa K, PARTRIDGE, Savannah C, SPECHT, Jennifer M

“…Although tightly coupled in most normal tissues, blood flow and metabolism are often not well matched in tumors. A flow-metabolism mismatch, specifically, high…”
Get full text

Serial 2-[18F] fluoro -2 -deoxy -D -glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP) by SPECHT, Jennifer M, TAM, Stephen L, KURLAND, Brenda F, GRALOW, Julie R, LIVINGSTON, Robert B, LINDEN, Hannah M, ELLIS, Georgiana K, SCHUBERT, Erin K, DUNNWALD, Lisa K, MANKOFF, David A

“…The response of bone-dominant (BD) breast cancer to therapy is difficult to assess by conventional imaging. Our preliminary studies have shown that…”
Get full text

SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors by Hope, Thomas A, Allen-Auerbach, Martin, Bodei, Lisa, Calais, Jeremie, Dahlbom, Magnus, Dunnwald, Lisa K, Graham, Michael M, Jacene, Heather A, Heath, Courtney Lawhn, Mittra, Erik S, Wright, Chadwick L, Fendler, Wolfgang P, Herrmann, Ken, Taïeb, David, Kjaer, Andreas

Get full text

Association between serial dynamic contrast-enhanced MRI and dynamic 18F-FDG PET measures in patients undergoing neoadjuvant chemotherapy for locally advanced breast cancer by Partridge, Savannah C., Vanantwerp, Risa K., Doot, Robert K., Chai, Xiaoyu, Kurland, Brenda F., Eby, Peter R., Specht, Jennifer M., Dunnwald, Lisa K., Schubert, Erin K., Lehman, Constance D., Mankoff, David A.

“…Purpose To investigate the relationship between changes in vascularity and metabolic activity measured by dynamic contrast‐enhanced magnetic resonance imaging…”
Get full text

Changes in Blood Flow and Metabolism in Locally Advanced Breast Cancer Treated with Neoadjuvant Chemotherapy by Mankoff, David A, Dunnwald, Lisa K, Gralow, Julie R, Ellis, Georgiana K, Schubert, Erin K, Tseng, Jeffrey, Lawton, Thomas J, Linden, Hannah M, Livingston, Robert B

“…Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy followed by definitive surgery. The factors influencing the response of…”
Get full text

SUV varies with time after injection in (18)F-FDG PET of breast cancer: characterization and method to adjust for time differences by Beaulieu, Sylvain, Kinahan, Paul, Tseng, Jeffrey, Dunnwald, Lisa K, Schubert, Erin K, Pham, Pam, Lewellen, Barbara, Mankoff, David A

“…The purpose of this study was to measure how (18)F-FDG PET standardized uptake values (SUVs) change over time in breast cancer and to examine the feasibility…”
Get full text

Blood Flow and Metabolism in Locally Advanced Breast Cancer: Relationship to Response to Therapy by Mankoff, David A, Dunnwald, Lisa K, Gralow, Julie R, Ellis, Georgiana K, Charlop, Aaron, Lawton, Thomas J, Schubert, Erin K, Tseng, Jeffrey, Livingston, Robert B

“…Locally advanced breast cancer (LABC) is commonly treated with neoadjuvant chemotherapy followed by definitive surgery. The factors influencing the response of…”
Get full text

Assessment of a statistical AIF extraction method for dynamic PET studies with 15O water and 18F fluorodeoxyglucose in locally advanced breast cancer patients by O’Sullivan, Finbarr, O’Sullivan, Janet N., Huang, Jian, Doot, Robert, Muzi, Mark, Schubert, Erin, Peterson, Lanell, Dunnwald, Lisa K., Mankoff, David M.

“…Blood flow-metabolism mismatch from dynamic positron emission tomography (PET) studies with O 15 -labeled water ( H 2 O ) and F 18 -labeled fluorodeoxyglucose…”
Get full text

Internal mammary nodal chain drainage is a prognostic indicator in axillary node-positive breast cancer by Yao, Michelle S, Kurland, Brenda F, Smith, Anne H, Schubert, Erin K, Dunnwald, Lisa K, Byrd, David R, Mankoff, David A

“…Internal mammary (IM) nodes are a potential site of breast lymphatic drainage. We examined the relationship between lymphoscintigraphic evidence of IM drainage…”
Get full text

Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma by Nason, Katie S., Anderson, Benjamin O., Byrd, David R., Dunnwald, Lisa K., Eary, Janet F., Mankoff, David A., Livingston, Robert, Schmidt, Rodney A., Jewell, Kim D., Yeung, Raymond S., Moe, Roger E.

“…BACKGROUND Sentinel lymph node dissection (SLND) has been a promising new technique in breast carcinoma staging, but could be unreliable in certain patient…”
Get full text

Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast cancer (LABC) by Bellon, Jennifer R, Livingston, Robert B, Eubank, William B, Gralow, Julie R, Ellis, Georgiana K, Dunnwald, Lisa K, Mankoff, David A

“…The presence of internal mammary (IM) lymph node metastases in breast cancer predicts outcome and may alter treatment. Standard imaging has limited usefulness…”
Get full text

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy by Stafford, Stephanie E, Gralow, Julie R, Schubert, Erin K, Rinn, Kristine J, Dunnwald, Lisa K, Livingston, Robert B, Mankoff, David A

“…The authors performed this study to determine the feasibility of using quantitative 2-[fluorine-18]fluoro-2-deoxy-D-glucose (FDG) positron emission tomography…”
Get more information

Between-patient and within-patient (site-to-site) variability in estrogen receptor binding, measured in vivo by 18F-fluoroestradiol PET by Kurland, Brenda F, Peterson, Lanell M, Lee, Jean H, Linden, Hannah M, Schubert, Erin K, Dunnwald, Lisa K, Link, Jeanne M, Krohn, Kenneth A, Mankoff, David A

“…Heterogeneity of estrogen receptor (ER) expression may be an important predictor of breast cancer therapeutic response. (18)F-fluoroestradiol PET produces in…”
Get full text

Metabolic and vascular features of dynamic contrast-enhanced breast magnetic resonance imaging and (15)O-water positron emission tomography blood flow in breast cancer by Eby, Peter R, Partridge, Savannah C, White, Steven W, Doot, Robert K, Dunnwald, Lisa K, Schubert, Erin K, Kurland, Brenda F, Lehman, Constance D, Mankoff, David A

“…We sought to (1) describe associations between measures of tumor perfusion by dynamic contrast-enhanced breast magnetic resonance imaging (DCE-MRI), blood flow…”
Get full text

Residual tumor uptake of [99mTc]‐sestamibi after neoadjuvant chemotherapy for locally advanced breast carcinoma predicts survival by Dunnwald, Lisa K., Gralow, Julie R., Ellis, Georgiana K., Livingston, Robert B., Linden, Hannah M., Lawton, Thomas J., Barlow, William E., Schubert, Erin K., Mankoff, David A.

“…BACKGROUND Studies utilizing serial [99mTc]‐sestamibi (MIBI) scintimammography have reported accurate prediction of tumor response in patients with locally…”
Get full text